Create Medic Co., Ltd. (TYO:5187)
1,091.00
-14.00 (-1.27%)
Nov 18, 2026, 3:30 PM JST
Create Medic Revenue
Create Medic had revenue of 3.54B JPY in the quarter ending September 30, 2026, with 1.29% growth. This brings the company's total for the last twelve months to 14.03B, up 3.37% year-over-year. In the year 2025, Create Medic had annual revenue of 13.62B with 4.50% growth. That makes Create Medic the 23,699th largest company in the world by revenue and 2,542nd in Japan.
Revenue (ttm)
14.03B
Revenue Growth
+3.37%
P/S Ratio
0.62
Revenue / Employee
13.89M
Employees
1,010
Market Cap
8.68B
Revenue by Geography
- Japan 9.02B 66.2%
- China 3.19B 23.4%
- Europe 1.12B 8.2%
- Others 294.44M 2.2%
Fiscal year ended Dec 31, 2025 See the full Create Medic breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.62B | 587.00M | 4.50% |
| Dec 31, 2024 | 13.03B | 445.00M | 3.54% |
| Dec 31, 2023 | 12.59B | 328.00M | 2.68% |
| Dec 31, 2022 | 12.26B | 559.00M | 4.78% |
| Dec 31, 2021 | 11.70B | 868.00M | 8.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Intermestic | 77.17B |
| France Bed Holdings | 63.26B |
| Seikagaku | 36.95B |
| Rion Co., Ltd. | 29.16B |
| Japan Medical Dynamic Marketing, INC. | 22.74B |
| TAUNS Laboratories,Inc. | 15.62B |
| Koken | 12.14B |
| Techno Medica | 11.59B |
Create Medic News
- 16 days ago - Create Medic Quarterly report: Q3 2026 - Filings
- 16 days ago - Create Medic Slides: Q3 2026 - Filings
- 3 months ago - Create Medic Quarterly report: Q2 2026 - Filings